Superworth

Innospec price to free cash flow IOSP

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Nov 2, 2026
35.0×
10-year median
22.0×
Against its 10-year history
82nd
percentile: 0 is its lowest day, 100 its highest
10-year range
11.4× to 105×
Peer median
24.0×

Innospec's price to free cash flow is 35.0× as of Nov 2, 2026.

That is above its ten-year median of 22.0×, higher than on 82% of days in the last ten years.

Over that time it ranged from 11.4× in Mar 2020 to 105× in Oct 2017.

The median for 10 chemicals stocks of a similar size is 24.0×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far35.0×18.6×39.1×
202535.4×14.2×35.4×
202414.9×14.3×22.1×
202319.7×16.2×85.8×
202276.5×41.9×82.8×
202147.2×15.9×49.0×
202019.0×11.4×19.0×
201917.9×15.1×32.4×
201826.9×22.0×55.1×
201752.9×16.5×105×
201617.1×9.3×18.0×
201510.7×9.3×14.0×
201414.1×13.6×55.9×
201357.3×11.9×59.6×
201210.9×10.0×18.4×

Against its peers

Companies in Chemicals nearest Innospec's size, closest first, today.

CompanyPrice to free cash flow
IOSPInnospec35.0×
NGVTIngevity16.4×
ROGRogers23.5×
FULFuller H B27.7×
WDFCWD 4031.3×
CBTCabot13.9×
AVNTAvient20.9×
CSWCSW Industrials26.4×
CRONCronos24.6×
BCPCBalchemn/m
HXLHexcel24.0×
Peer median24.0×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Innospec

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.